{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-054353","form_type":"8-K","ticker":"GMED","cik":"0001237831","company_name":"GLOBUS MEDICAL INC","filed_at":"2026-08-06T20:19:48+00:00","discovered_at":"2026-08-06T20:21:00.308972+00:00","generated_at":"2026-08-06T20:22:15.508828+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Globus Medical Q2 net sales $789.6M (+5.9%); non-GAAP EPS $1.34 (+55.8%), raises FY EPS guidance","bullets":["Worldwide net sales $789.6M, +5.9% YoY; US +3.0%, International +18.0% as-reported.","GAAP diluted EPS $1.10 (-26.2% YoY) due to prior-year bargain purchase gain; non-GAAP diluted EPS $1.34 (+55.8%).","US Spine grew 7% YoY; International Spine grew 14% as-reported (12% constant currency).","Adjusted gross margin expanded 200 bps YoY; record Q2 non-GAAP net income and EPS.","FY2026 revenue guidance reaffirmed $3.18B-$3.22B; non-GAAP EPS guidance raised to $4.95-$5.05 from $4.70-$4.80."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-054353","json":"https://secwatch.observer/filing/0001628280-26-054353.json","markdown":"https://secwatch.observer/filing/0001628280-26-054353.md","text":"https://secwatch.observer/filing/0001628280-26-054353.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/0001628280-26-054353-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1237831/000162828026054353/gmed-20260806.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:22:15.508828+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}